NATCO Pharma Limited (NSE:NATCOPHARM)
India
· Delayed Price · Currency is INR 1,002.70
-17.00 (-1.67%)
At close: Mar 9, 2026
NATCO Pharma Employees
NATCO Pharma had 4,199 employees as of March 31, 2025. The number of employees increased by 183 or 4.56% compared to the previous year.
Employees
4,199
Change (1Y)
183
Growth (1Y)
4.56%
Revenue / Employee
10.87M INR
Profits / Employee
3.71M INR
Market Cap
179.59B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| Eris Lifesciences | 3,354 |
| Piramal Pharma | 5,476 |
| Wockhardt | 2,296 |
| Alembic Pharmaceuticals | 16,571 |
| Emcure Pharmaceuticals | 6,731 |
| Gland Pharma | 4,351 |
| Alivus Life Sciences | 2,203 |
| Cohance Lifesciences | 1,212 |
NATCO Pharma News
- 3 days ago - Pharma sector stocks today, March 6: Shilpa Medicare surge 3.08%, Wockhardt jumps 2.12%, Natco Pharma up 1.84%, - Business Upturn
- 4 days ago - Pharma sector stocks surge today, March 5: Natco Pharma jumps 3.35%, Granules India up 2.74%, Alembic surge nearly 2% - Business Upturn
- 5 days ago - Natco Pharma shares rise over 2% after launch of generic Pomalidomide Capsules in the US - Business Upturn
- 6 days ago - Natco Pharma launches Generic Pomalidomide Capsules in US market - Business Upturn
- 7 days ago - Pharma sector stocks down today, March 2: Morepen Lab falls 3.24%, Ajanta Pharma drops 2.32%, Natco Pharma down 2.26% - Business Upturn
- 10 days ago - Pharma sector stocks today, Feb 27: Dr. Reddys Lab down 1.14%, Cipla falls 1.04%, Natco Pharma up 1.09% - Business Upturn
- 12 days ago - NATCO Pharma clarifies on Semaglutide launch plans; says no material impact from Eris partnership news - Business Upturn
- 13 days ago - Eris Lifesciences partners with Natco Pharma to launch Semaglutide in India - Business Upturn